RA Capital Management, L.P. 13D/13G Filings for iTeos Therapeutics, Inc. (ITOS)

RA Capital Management, L.P. 13D and 13G filings for iTeos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-05-14
9:10 pm
Sale		 2024-05-10 13D iTeos Therapeutics, Inc.
ITOS		 RA Capital Management, L.P. 3,659,046
9.990%		 -758,213decrease
(-17.16%)		 Filing
2020-08-05
4:30 pm
Purchase		 2009-02-28 13D iTeos Therapeutics, Inc.
ITOS		 RA Capital Management, L.P. 4,417,259
13.200%		 4,417,259increase
(New Position)		 Filing